This inventor holds 2 USPTO granted patents. Top assignees: Pharmachim, Tpo 'Pharmachim'. Active years: 1987-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1990
Title: Radi G Ovcharov: Innovator in Ophthalmic Solutions
Introduction
Radi G Ovcharov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 2 patents, his work reflects a commitment to advancing medical solutions.
Latest Patents
Ovcharov's latest patents include a composition and method for treating glaucoma. This antiglaucoma composition features an active component, a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The formulation is designed for use as an ophthalmic solution, administered in therapeutic doses of 2 to 3 drops two to four times daily to warm-blooded animals suffering from glaucoma. Another patent involves compounds of the formula (I), which have the ability to inhibit adenylate cyclase, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Throughout his career, Ovcharov has worked with prominent companies such as TPO Pharmachim and Pharmachim. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective treatments.
Collaborations
Ovcharov has collaborated with notable colleagues, including Chavdar B Ivanov and Nikolina D Berova. These partnerships have further enriched his research and development efforts in the field of ophthalmology.
Conclusion
Radi G Ovcharov stands out as a dedicated inventor whose work in glaucoma treatment exemplifies innovation in the medical field. His contributions continue to impact the lives of those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile